Michael Lim, MD
Geriatric Medicine · Arlington Heights, ILNPI 1730294307
Payments from drug & device makers
Across 789 payments — averaging $37.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$5K
- Amgen$4K
- Lilly USA, LLC$3K
- Novo Nordisk$3K
- AstraZeneca$3K
- Johnson & Johnson$3K
- plus $9K from 29 others
What the payments were for
- Food & beverage$29,349100%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 127 | $5,434 |
| Amgen | 99 | $3,702 |
| Lilly USA, LLC | 112 | $3,055 |
| Novo Nordisk | 82 | $2,787 |
| AstraZeneca(2 entities) | 67 | $2,650 |
| Johnson & Johnson | 68 | $2,575 |
| Abbott | 14 | $1,500 |
| Pfizer | 34 | $1,162 |
| Amarin Pharma, Inc. | 22 | $862 |
| E.r. Squibb & Sons, L.L.C. | 18 | $790 |
| Bayer | 19 | $554 |
| Esperion Therapeutics, Inc. | 8 | $531 |
| Sanofi-aventis U.S. LLC | 8 | $467 |
| Corcept Therapeutics | 14 | $466 |
| Otsuka America Pharmaceutical, Inc. | 8 | $442 |
| Novartis | 14 | $355 |
| GSK | 8 | $318 |
| Phathom Pharmaceuticals, Inc. | 6 | $316 |
| Axsome Therapeutics, Inc. | 4 | $271 |
| Merck | 13 | $226 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $208 |
| Exact Sciences | 8 | $172 |
| Lundbeck LLC | 7 | $136 |
| Idorsia Pharmaceuticals US Inc | 1 | $81 |
| Lexicon Pharmaceuticals, Inc. | 2 | $55 |
| Currax Pharmaceuticals LLC | 3 | $50 |
| Edwards Lifesciences | 1 | $45 |
| AbbVie | 2 | $39 |
| Shield Therapeutics Inc | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Theracosbio, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,374 in reported general payments places this provider in the 95th percentile of 147 geriatric medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 28 | $39,796 |
| JardianceEmpagliflozin | 37 | $35,987 |
| FarxigaDapagliflozin Propanediol | 24 | $35,600 |
| EliquisApixaban | 32 | $29,474 |
| MounjaroTirzepatide | 26 | $28,934 |
| XareltoRivaroxaban | 19 | $22,402 |
| OzempicSemaglutide | 15 | $19,379 |
| RexultiBrexpiprazole | 11 | $12,932 |
| GlyxambiEmpagliflozin/Linagliptin | 13 | $12,449 |
| Rosuvastatin Calcium | 226 | $3,291 |
| SynthroidLevothyroxine Sodium | 35 | $2,671 |
| Metoprolol Succinate | 96 | $1,989 |
| Atorvastatin Calcium | 193 | $1,778 |
| Ezetimibe | 23 | $1,399 |
| Tamsulosin Hcl | 48 | $1,133 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $3,055 | $68,73054 claims |
| Boehringer IngelheimJardiance, Glyxambi | $5,434 | $48,43650 claims |
| AstraZenecaFarxiga | $2,650 | $35,60024 claims |
| PfizerEliquis | $1,162 | $29,47432 claims |
| Johnson & JohnsonXarelto | $2,575 | $22,40219 claims |
| Novo NordiskOzempic | $2,787 | $19,37915 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $442 | $12,93211 claims |
| AbbVieSynthroid | $39 | $2,67135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 147 geriatric medicine providers in Illinois.
Other geriatric medicine in Arlington Heights
- Thomas CozziArlington Heights$3K
- Raj ShahChicago$1.8M
- Xinqi DongChicago$214K
- Patricia BurkeChicago$28K
- Hima AtluriDecatur$21K
- Carlos Mella-PicelChicago$9K
- Rekha SharmaHazel Crest$8K
- Beata StykaPalos Heights$6K
- Azeem AhsanCrest Hill$6K
- Adeela CheemaChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.